Neurorenal Autoimmunity Unveiled: Atypical Guillain-Barre Syndrome with Concurrent NELL-1-Positive Membranous Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0689; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "However, in patients with persistent nephrotic syndrome or relapse, escalation to systemic immunosuppression, including B cell directed therapy such as rituximab or cytotoxic therapy with cyclophosphamide is warranted. Treatment decisions will depend on neurologic severity, renal findings, and overall disease trajectory. Nell-1 Staining of a Membranous Glomerulus"
Complement-mediated Rare Disorders • Glomerulonephritis • Nephrology • Renal Disease • EGF • NELL1
|
|
Garo Christopher Kalfayan; Anita Kamarzarian; Elaine J. Oldford; Golriz Jafari; Phuong-Chi T. Pham; Mercury Y. Lin
|